First People Sickened By COVID-19 Were Chinese Scientists

New Post Public Reply Private Reply Replies (0) Message Board
energy_wave energy_wave #46157
429
First People Sickened By COVID-19 Were Chinese Scientists At Wuhan Institute Of Virology, Say US Government Sources

Quote:
After years of official pronouncements to the contrary, significant new evidence has emerged that strengthens the case that the SARS-CoV-2 virus accidentally escaped from the Wuhan Institute of Virology (WIV).

According to multiple U.S. government officials interviewed as part of a lengthy investigation by Public and Racket, the first people infected by the virus, “patients zero,” included Ben Hu, a researcher who led the WIV’s “gain-of-function” research on SARS-like coronaviruses, which increases the infectiousness of viruses.

More than three years after the pandemic’s outbreak, many around the world had given up on learning the origin of SARS-CoV-2, the highly infectious respiratory virus that has killed millions, and the response to which shut down businesses and schools, upended societies, and caused enormous collateral damage.

Public officials in the U.S. and other countries have repeatedly suggested that uncovering the pandemic’s origin may not be possible. “We may never know,” said Anthony Fauci, the former director of the National Institute of Allergy and Infectious Diseases, who oversaw pandemic response for two administrations.

Now, answers increasingly look within reach. Sources within the US government say that three of the earliest people to become infected with SARS-CoV-2 were Ben Hu, Yu Ping, and Yan Zhu. All were members of the Wuhan lab suspected to have leaked the pandemic virus.

As such, not only do we know there were WIV scientists who had developed COVID-19-like illnesses in November 2019, but also that they were working with the closest relatives of SARS-CoV-2, and inserting gain-of-function features unique to it.

When a source was asked how certain they were that these were the identities of the three WIV scientists who developed symptoms consistent with COVID-19 in the fall of 2019, we were told, “100%”

“Ben Hu is essentially the next Shi Zhengli,” said Alina Chan, a molecular biologist at the Broad Institute of MIT and Harvard, and coauthor with Matt Ridley of Viral: The Search for the Origin of Covid19. Shi is known as “the bat woman of China,” and led the gain-of-function research at the WIV. “He was her star pupil. He had been making chimeric SARS-like viruses and testing these in humanized mice. If I had to guess who would be doing this risky virus research and most at risk of getting accidentally infected, it would be him.”

Hu and Yu researched the novel lineage of SARS-like viruses from which SARS-CoV-2 hails, and in 2019 coauthored a paper with Shi Zhengli that described SARS-like lineages they had studied over the years.

Jamie Metzl, a former member of the World Health Organization expert advisory committee on human genome editing who raised questions starting in early 2020 about a possible research-related pandemic origin, said, “It’s a game changer if it can be proven that Hu got sick with COVID-19 before anyone else. That would be the ‘smoking gun.’ Hu was the lead hands-on researcher in Shi’s lab.”

Sources tell Public and Racket that other news organizations are chasing aspects of this story. On Saturday, The Times of London quoted an anonymous U.S. State Department investigator saying, “It has become increasingly clear that the Wuhan Institute of Virology was involved in the creation, promulgation, and cover-up of the Covid-19 pandemic.”

Public and Racket are the first publications to reveal the names of the three sick WIV workers and place them directly in the lab that collected and experimented with SARS-like viruses poised for human emergence.

Next week, the Directorate of National Intelligence is expected to release previously classified material, which may include the names of the three WIV scientists who were the likely among the first to be sickened by SARS-CoV-2.

A bill signed by President Biden earlier this year specifically called for the release of the names and roles of the sick researchers at the WIV, their symptoms and date of symptom onset, and whether these researchers had been involved with or exposed to coronavirus research.

On Dec. 29, 2017, two years before the pandemic began, Chinese state-run television aired a video that includes a scene of Ben Hu watching a lab worker handle specimens. Neither are wearing protective gear. The same video shows WIV scientists hunting for bat viruses with little protective gear. “If they were worried about being infected in the field, they would need full body suits with no gaps” to be safe, said Chan. “That’s the only way.”

The WIV research with live SARS-like viruses was performed at too low of a safety level, “BSL-2,” explains Chan, “When we now know that the pandemic virus is even capable of escaping from a BSL-3 lab and infecting fully vaccinated young lab workers.”

While scientists justify such research as necessary for developing vaccines, President Barack Obama banned federal funding for gain-of-function research of concern in 2014, because experts had come to the consensus that it was too dangerous. However, the National Institute of Health and NIAID headed by Francis Collins and Fauci, and a major U.S. government grantee, EcoHealth Alliance, deemed their work on SARS-like viruses as not falling under the gain-of-function research of concern definitions and funded this project in China and Southeast Asia.

In March 2018, the WIV, the EcoHealth Alliance, and the University of North Carolina applied for a $14 million grant from the U.S. Defense Advanced Research Project Agency DARPA to engineer “furin cleavage sites” into SARS-like coronaviruses to study how this affected their ability to grow and cause disease.

Scientists say the key piece of the COVID-19 virus, which made it so transmissible compared to its closest relatives, was its unique furin cleavage site.

DARPA rejected the grant, but it now appears the WIV went forward with the research anyway. The Times of London reported that US collaborators of the WIV had come forward and said the Wuhan scientists had put furin cleavage sites into SARS-like viruses in 2019.

Hu co-authored multiple papers on coronavirus research, including a 2017 paper on chimeric bat coronaviruses with Peter Daszak, the head of EcoHealth Alliance, which was funded in part by the NIH and the USAID Emerging Pandemic Threats PREDICT Program. Data privately shared with the NIH revealed that these chimeric SARS-like viruses grew far more quickly and caused more severe disease in humanized mice in the lab.

When the WIV put out their first paper about the pandemic virus, they failed to point out the novel furin cleavage site despite having had plans to and allegedly putting such gain-of-function features into SARS-like viruses in their lab. “It’s as if these scientists proposed putting horns on horses, but when a unicorn shows up in their city a year later they write a paper describing every part of it except its horn,” said Chan.

Public sent emails and made phone calls to the NIH, WIV, EcoHealth Alliance, Daszak, Hu, and Shi over the last several days and did not hear back.

It is unclear who in the U.S. government had access to the intelligence about the sick WIV workers, how long they had it, and why it was not shared with the public. “You would expect the country of origin to be defensive,” said Chan, “but you wouldn’t expect a country receiving the virus to be withholding key evidence.”

On January 15, 2021, five days before President Joe Biden took office, the U.S. State Department published a fact sheet that pointed to the likelihood of a lab leak as the cause of a pandemic.

Already, the State Department in 2021 suspected that the WIV had lied to the public. “The U.S. government has reason to believe that several researchers inside the WIV became sick in autumn 2019, before the first identified case of the outbreak, with symptoms consistent with both COVID-19 and common seasonal illnesses. That raises questions about the credibility of WIV senior researcher Shi Zhengli’s public claim that there was ‘zero infection’ among the WIV’s staff and students by SARS-CoV-2 or SARS-related viruses.”

In February of this year, the Director of the FBI, Christopher Wray, told a reporter that “the FBI has for quite some time now assessed that the origins of the pandemic are most likely a potential lab incident in Wuhan.”

The Times of London reported that State Department investigators “found evidence that researchers working on these experiments were taken to hospital with Covid-like symptoms in November 2019.” As previously reported in Vanity Fair, some of the information State Department investigators found in 2021 was “sitting in the U.S. intelligence community’s own files, unanalyzed.”

“Ever since I put out my [May 2020] preprint [research paper] saying that an accidental lab origin was possible, I was criticized as a conspiracy theorist,” said Chan. “If this info had been made public in May of 2020, I doubt that many in the scientific community and the media would have spent the last three years raving about a raccoon dog or pangolin in a wet market.”

Identifying the first COVID-19 case as a Wuhan Institute scientist overseeing gain-of-function research has significant ramifications for investigators in search of a motive for a cover-up.

Politicians, scientists, journalists, and amateur researchers for years now have zeroed in on the possibility that Covid-19 may have resulted from U.S.-funded gain-of-function research conducted in China.

Publications ranging from the Washington Post to the Intercept to the Wall Street Journal have uncovered suggestive details, including the fact that the NIH awarded funding for at least 18 gain-of-function research projects between 2012 and 2020, and NIH scientists in 2016 expressing concern about supposedly paused hybrid “chimera” virus research.

Had the information come out earlier, governments may have responded to the pandemic differently. After Public shared the information with Chan, she said, “I feel vindicated, but I’m frustrated. If you knew that this was likely a lab-enhanced pathogen, there are so many things you could have done differently. This whole pandemic could have been reshaped.”

Said Metzl, “Had US government officials including Dr. Fauci stated from day one that a COVID-19 research-related origin was a very real possibility, and made clear that we had little idea what viruses were being held at the Wuhan Institute of Virology, what work was being done there, and who was doing that work, our national and global conversations would have been dramatically different. The time has come for a full accounting.”


https://www.zerohedge.com/covid-19/first-peop...ogy-say-us
big-wave_surfing_01.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

Endeavour Mining Sees Significant Stake Notification from BlackRock

Updated Category News Views 141

Endeavour Mining and Major Shareholding Update Endeavour Mining plc is making headlines with its latest update regarding shareholders. Recently, the company received a notable notification from BlackRock, Inc., one of the world’s leading investment management firms. This announcement highlights BlackRock's interests in Endeavour Mining, showcasing the ongoing...

Continue Reading
Concerns Rise as Collaborative Leaders Depart Congress Rapidly

Updated Category News Views 48

New Findings on Congressional Collaboration Recently, an insightful report emerged emphasizing the ongoing shifts within Congress, revealing a notable trend that could hinder bipartisan efforts. The analysis underscores the departures of many collaborative members, dubbed 'bridgers', poised to leave their positions, thus raising alarms about the future of political...

Continue Reading
Latest Safety Recalls: Critical Updates on Consumer Products

Updated Category News Views 271

Consumer product recalls can ripple through markets faster than a bad earnings report. Back in mid-2024, we saw some significant shake-ups with companies like John Deere and Liberty Hardware facing public scrutiny over safety issues. For traders, these incidents aren’t just corporate headaches; they’re potential red flags on the balance sheets that could send stock...

Continue Reading
Investors Unite: ASP Isotopes Inc. Faces Major Legal Challenge

Updated Category News Views 118

Understanding the Legal Challenge Against ASP Isotopes Inc. The Schall Law Firm, recognized for its commitment to investor rights, has brought significant attention to a recent class action lawsuit involving ASP Isotopes Inc. (NASDAQ: ASPI). This lawsuit addresses serious allegations regarding the company's transparency and accuracy in reporting its technological...

Continue Reading
Elyce Arons: Keynote Speaker and Honorary Doctorate Recipient

Updated Category News Views 101

Elyce Arons to Speak at LIM College Commencement Elyce Arons, the Founder and CEO of Frances Valentine, is set to take the stage as the keynote speaker at the upcoming commencement ceremony for the Class of 2026 at LIM College. This prestigious event will highlight her journey and accomplishments within the fashion industry, inspiring graduates to chase their dreams....

Continue Reading